Home / Publications / Anticancer activity of new benzofuroxan–imidazolone hybrids

Anticancer activity of new benzofuroxan–imidazolone hybrids

Elena Alexandrovna Chugunova 1
Elena Alexandrovna Chugunova
Andrey Vladimirovich Smolobochkin 1
Andrey Vladimirovich Smolobochkin
Almir Sabirovich Gazizov 1
Almir Sabirovich Gazizov
Alexander Romanovich Burilov 1
Alexander Romanovich Burilov
Alexandra Dmitrievna Voloshina 1
Alexandra Dmitrievna Voloshina
Anna Pavlovna Lyubina 1
Anna Pavlovna Lyubina
Syumbel Kamilevna Amerhanova 1
Syumbel Kamilevna Amerhanova
Tatyana A Melnikova 2
Tatyana A Melnikova
Alena I Tulesinova 2
Alena I Tulesinova
Nurgali Ikramovich Akylbekov 3
Nurgali Ikramovich Akylbekov
Nurlybek A Akhatayev 3
Nurlybek A Akhatayev
Victor Vasil'evich Syakaev 1
Victor Vasil'evich Syakaev
Published 2021-11-08
CommunicationVolume 31, Issue 6, 865-866
2
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Chugunova E. A. et al. Anticancer activity of new benzofuroxan–imidazolone hybrids // Mendeleev Communications. 2021. Vol. 31. No. 6. pp. 865-866.
GOST all authors (up to 50) Copy
Chugunova E. A., Smolobochkin A. V., Gazizov A. S., Burilov A. R., Voloshina A. D., Lyubina A. P., Amerhanova S. K., Melnikova T. A., Tulesinova A. I., Akylbekov N. I., Akhatayev N. A., Syakaev V. V. Anticancer activity of new benzofuroxan–imidazolone hybrids // Mendeleev Communications. 2021. Vol. 31. No. 6. pp. 865-866.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2021.11.032
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2021.11.032
TI - Anticancer activity of new benzofuroxan–imidazolone hybrids
T2 - Mendeleev Communications
AU - Chugunova, Elena Alexandrovna
AU - Smolobochkin, Andrey Vladimirovich
AU - Gazizov, Almir Sabirovich
AU - Burilov, Alexander Romanovich
AU - Voloshina, Alexandra Dmitrievna
AU - Lyubina, Anna Pavlovna
AU - Amerhanova, Syumbel Kamilevna
AU - Melnikova, Tatyana A
AU - Tulesinova, Alena I
AU - Akylbekov, Nurgali Ikramovich
AU - Akhatayev, Nurlybek A
AU - Syakaev, Victor Vasil'evich
PY - 2021
DA - 2021/11/08
PB - Mendeleev Communications
SP - 865-866
IS - 6
VL - 31
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Chugunova,
author = {Elena Alexandrovna Chugunova and Andrey Vladimirovich Smolobochkin and Almir Sabirovich Gazizov and Alexander Romanovich Burilov and Alexandra Dmitrievna Voloshina and Anna Pavlovna Lyubina and Syumbel Kamilevna Amerhanova and Tatyana A Melnikova and Alena I Tulesinova and Nurgali Ikramovich Akylbekov and Nurlybek A Akhatayev and Victor Vasil'evich Syakaev},
title = {Anticancer activity of new benzofuroxan–imidazolone hybrids},
journal = {Mendeleev Communications},
year = {2021},
volume = {31},
publisher = {Mendeleev Communications},
month = {Nov},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2021.11.032},
number = {6},
pages = {865--866},
doi = {10.1016/j.mencom.2021.11.032}
}
MLA
Cite this
MLA Copy
Chugunova, Elena Alexandrovna, et al. “Anticancer activity of new benzofuroxan–imidazolone hybrids.” Mendeleev Communications, vol. 31, no. 6, Nov. 2021, pp. 865-866. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2021.11.032.

Keywords

antitumor activity
benzofuroxans
hybrid compounds
imidazol-2-ones
regioselective synthesis
SNAr reaction

Abstract

Novel hybrid compounds containing both benzofuroxan and 1H-imidazol-2(3H)-one moieties were synthesized by an SNAr reaction between 7-chloro-4,6-dinitrobenzofuroxan and imidazol-2-ones, with the only C4 regioisomer having been formed. Cytotoxic effects of parent and obtained compounds were estimated on human cancer and normal cells, while two of imidazolones showed higher cytotoxicity in relation to the M-HeLa cancer line compared to the hybrid products. In relation to the normal liver cell line Chang, the tested compounds were found to be non-toxic and can be promising for further development of anticancer agents.

References

1.
Synthesis and Anticancer Activity of All Known (−)-Agelastatin Alkaloids
Han S., Siegel D.S., Morrison K.C., Hergenrother P.J., Movassaghi M.
Journal of Organic Chemistry, 2013
2.
Caprolactams as potent CGRP receptor antagonists for the treatment of migraine
Shaw A.W., Paone D.V., Nguyen D.N., Stump C.A., Burgey C.S., Mosser S.D., Salvatore C.A., Rutledge R.Z., Kane S.A., Koblan K.S., Graham S.L., Vacca J.P., Williams T.M.
Bioorganic and Medicinal Chemistry Letters, 2007
3.
5-Aryl-imidazolin-2-ones as a scaffold for potent antioxidant and memory-improving activity
Watanabe K., Morinaka Y., Hayashi Y., Shinoda M., Nishi H., Fukushima N., Watanabe T., Ishibashi A., Yuki S., Tanaka M.
Bioorganic and Medicinal Chemistry Letters, 2008
4.
10.1016/j.mencom.2021.11.032_b0020
Comprehensive Natural Products III, 2020
5.
10.1016/j.mencom.2021.11.032_b0025
Bunag
in xPharm: The Comprehensive Pharmacology Reference, eds, 2007
6.
10.1016/j.mencom.2021.11.032_b0030
Davis
in xPharm: The Comprehensive Pharmacology Reference, eds, 2007
7.
Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)
Sheppeck J.E., Gilmore J.L., Tebben A., Xue C., Liu R., Decicco C.P., Duan J.J.
Bioorganic and Medicinal Chemistry Letters, 2007
8.
10.1016/j.mencom.2021.11.032_b0040
Kitazaki
Chem. Pharm. Bull., 1935
9.
Discovery of the first antibacterial small molecule inhibitors of MurB
Bronson J.J., DenBleyker K.L., Falk P.J., Mate R.A., Ho H., Pucci M.J., Snyder L.B.
Bioorganic and Medicinal Chemistry Letters, 2003
10.
Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents
Xue N., Yang X., Wu R., Chen J., He Q., Yang B., Lu X., Hu Y.
Bioorganic and Medicinal Chemistry, 2008
12.
1,3-Dihydro-2H-imidazol-2-one Derivatives: Synthesis and Applications (A Review)
Zav'yalov S.I., Ezhova G.I., Kravchenko N.E., Kulikova L.B., Dorofeeva O.V., Rumyantseva E.E., Zavozin A.G.
Pharmaceutical Chemistry Journal, 2004
13.
Methods for the synthesis of 1-substituted 1H-imidazol-2(3H)-ones
Antonova M.M., Baranov V.V., Kravchenko A.N.
Chemistry of Heterocyclic Compounds, 2015
16.
Synthesis and some properties of 2H-benzimidazole 1,3-dioxides
Chugunova E., Samsonov V., Gerasimova T., Rybalova T., Bagryanskaya I.
Tetrahedron, 2015
17.
Synthesis of novel 2-(Het)arylpyrrolidine derivatives and evaluation of their anticancer and anti-biofilm activity
Smolobochkin A., Gazizov A., Sazykina M., Akylbekov N., Chugunova E., Sazykin I., Gildebrant A., Voronina J., Burilov A., Karchava S., Klimova M., Voloshina A., Sapunova A., Klimanova E., Sashenkova T., et. al.
Molecules, 2019
18.
Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes
Claudio Viegas-Junior, Eliezer J. Barreiro, Carlos Alberto Manssour Fraga
Current Medicinal Chemistry, 2007
19.
Synthesis of the first tertiary ammonium derivative of 6-chloro-5-nitrobenzofuroxan
Chugunova E.A., Akylbekov N.I., Appazov N.O., Makhrus E.M., Burilov A.R.
Russian Journal of Organic Chemistry, 2016
20.
Synthesis of amino acid derivatives of benzofuroxan
Serkov I.V., Chugunova E.A., Burilov A.R., Bachurin S.O.
Doklady Chemistry, 2013
21.
Burilov A.R., Khakimov M.S., Gazizov A.S., Pudovik M.A., Syakaev V.V., Krivolapov D.B., Konovalov A.I.
Mendeleev Communications, 2008
22.
Carbon Nucleophilicities of Indoles in SNAr Substitutions of Superelectrophilic 7-Chloro-4,6-dinitrobenzofuroxan and -benzofurazan
Rodriguez-Dafonte P., Terrier F., Lakhdar S., Kurbatov S., Goumont R.
Journal of Organic Chemistry, 2009
23.
Superelectrophilic heterocycles: facile SNAr–SEAr couplings involving very weak carbon nucleophiles
Kurbatov S., Rodriguez-Dafonte P., Goumont R., Terrier F.
Chemical Communications, 2003
24.
C-C Coupling Reactions between Benzofurazan Derivatives and 1,3-Diaminobenzenes
25.
Lithiation of 1-arylimidazol-2(1H)-ones and 1-aryl-4,5-dihydroimidazol-2(1H)-ones
Llopart C.C., Ferrer C., Joule J.A.
Canadian Journal of Chemistry, 2004
26.
Synthesis of hybrids of benzofuroxan and N-, S-containing sterically hindered phenols derivatives. Tautomerism
Chugunova E., Akylbekov N., Shakirova L., Dobrynin A., Syakaev V., Latypov S., Bukharov S., Burilov A.
Tetrahedron, 2016
27.
Antimicrobial and cytotoxic effects of ammonium derivatives of diterpenoids steviol and isosteviol
Voloshina A.D., Sapunova A.S., Kulik N.V., Belenok M.G., Strobykina I.Y., Lyubina A.P., Gumerova S.K., Kataev V.E.
Bioorganic and Medicinal Chemistry, 2021